Hindustan Bio Sciences Ltd
Wed 2/09/2026,16:1:0 | BSE : HINDBIO
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 7.91
Previous Close
₹ 7.91
Volume
9662
Mkt Cap ( ₹ Cr)
₹ 7.71
High
₹ 8.23
Low
₹ 7.52
52 Week High
₹ 9.92
52 Week Low
₹ 5.00
Book Value Per Share
₹ 0.69
Dividend Yield
₹ 0.00
Face Value
₹₹2.00
What's Your Call?
Collective community sentiment on Hindustan Bio Sciences Ltd
Your Vote -
Buy
83.33%
Hold
0.00%
Sell
16.67%
83.33%
6 users have voted
Option Chain
Analyzes market sentiment, predicts Hindustan Bio Sciences Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Hindustan Bio Scienc - Board Meeting Outcome for Outcome Of Board Meeting
-
Hindustan Bio Scienc - Board Meeting Intimation for To Consider The Draft Scheme Of Reorganization/Rearrangement Of Share Cap
-
Hindustan Bio Scienc - Results For The Quarter Ended 30Th June 2026
-
Hindustan Bio Scienc - Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday, July 31 2026 As Required Under
-
Hindustan Bio Scienc - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 (1) (A) Of SEBI (Listing
-
Hindustan Bio Scienc has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026
-
Hindustan Bio Scienc - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Key fundamentals
Evaluate the intrinsic value of Hindustan Bio Sciences Ltd stockÂ
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 3.1755 | 3.4101 | 3.3605 | 3.2019 | 2.9535 |
| Liabilities | 3.1755 | 3.4101 | 3.3605 | 3.2019 | 2.9535 |
| Equity | 2.0502 | 2.0502 | 2.0501 | 2.0501 | 10.2508 |
| Gross Profit | -0.0583 | 0.0998 | 0.0638 | -0.0281 | -0.5061 |
| Net Profit | -0.079 | 0.1007 | 0.0575 | -0.0404 | -0.5175 |
| Cash From Operating Activities | 0.2813 | 0.0271 | -1.4089 | -0.0497 | -0.3427 |
| NPM(%) | -10.71 | 12.38 | 5.47 | -4.38 | -120.18 |
| Revenue | 0.7371 | 0.8133 | 1.0527 | 0.9223 | 0.4306 |
| Expenses | 0.7954 | 0.7135 | 0.9889 | 0.9505 | 0.9367 |
| ROE(%) | -11.07 | 14.12 | 8.07 | -5.67 | -72.58 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Hindustan Bio Sciences Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| GRM Overseas Ltd | 85.41 | 0.04 | 23.31 | 45.18 | 179.39 | 0.00 |
| Jain Irrigation Systems Ltd | 28.26 | 0.75 | 0.00 | 552.63 | -17.22 | 0.00 |
| Tierra Agrotech Ltd | 51.89 | 4.07 | 0.00 | 49.39 | -7.60 | 0.00 |
| Kohinoor Foods Ltd | 33.38 | -0.03 | 1.46 | 27.91 | 217.58 | 0.00 |
Company Info
Established in 2000, Hindustan Bio Sciences Limited (HBSL) is an integrated firm with diversified operations in pharmaceutical and biotechnology sectors. The company initially commenced operations by sourcing bulk drugs (APIs) and drug intermediates for the Industry with a wellspring of global suppliers and associates. In the year 2007 the company obtained the import license from Genetic Engineering Approval Committee (GEAC) for a nephrology product "Recombinant Human Erythropotien" after conducting clinical trials of the same. The company has been marketing the niche drug extensively ever since. The Company to its credit has world class manufacturing facilities for dry and liquid injectables, liquid/dry syrups, Eye/Ear/Nasal drops, pre-filled syringes and non sterile/sterile ointments, tablets and capsules approved by several regulatory authorities and is trusted by healthcare professionals and patients across the globe. 2001 - The Company has entered into an agreement with CDSL, NSDL and Venture Capital & Corporate Investments Ltd (R&T agents) for dematerialisation. 2004 -Hindustan Bio bags GEAC nod recombinant human erythropoietin 2005 -Hindustan Bio Sciences Ltd has received an order for Antiretroviral drug for a value of Rs 269.30 million from China.
Established in 2000, Hindustan Bio Sciences Limited (HBSL) is an integrated firm with diversified operations in pharmaceutical and biotechnology sectors. The company initially commenced operations by sourcing bulk drugs (APIs) and drug intermediates for the Industry with a wellspring of global suppliers and associates. In the year 2007 the company obtained the import license from Genetic Engineering Approval Committee (GEAC) for a nephrology product "Recombinant Human Erythropotien" after conducting clinical trials of the same. The company has been marketing the niche drug extensively ever since. The Company to its credit has world class manufacturing facilities for dry and liquid injectables, liquid/dry syrups, Eye/Ear/Nasal drops, pre-filled syringes and non sterile/sterile ointments, tablets and capsules approved by several regulatory authorities and is trusted by healthcare professionals and patients across the globe. 2001 - The Company has entered into an agreement with CDSL, NSDL and Venture Capital & Corporate Investments Ltd (R&T agents) for dematerialisation. 2004 -Hindustan Bio bags GEAC nod recombinant human erythropoietin 2005 -Hindustan Bio Sciences Ltd has received an order for Antiretroviral drug for a value of Rs 269.30 million from China.
Read More
Parent Organisation
Hindustan Bio Sciences Ltd.
Founded
13/12/1991
Managing Director
Mr.J V R Mohan Raju
NSE Symbol
FAQ
The current price of Hindustan Bio Sciences Ltd is
The 52-week high for Hindustan Bio Sciences Ltd is
The market capitalization of Hindustan Bio Sciences Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Hindustan Bio Sciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Hindustan Bio Sciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Hindustan Bio Sciences Ltd shares.
The CEO of Hindustan Bio Sciences Ltd is Mr.J V R Mohan Raju, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
